Search for: "State v. Flom" Results 1 - 20 of 178
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Apr 2024, 9:01 pm by renholding
The Court of Chancery recently examined such an agreement in In West Palm Beach Firefighters’ Pension Fund v. [read post]
12 Apr 2024, 6:30 am
Gubler (Arizona State University), on Monday, April 8, 2024 Tags: corporate boards, corporate law, directors, Fiduciary duties, Shareholder value, Stakeholders Delaware Supreme Court Holds Entire Fairness Applicable to All Conflicted Controller Transactions Posted by Gregory V. [read post]
12 Apr 2024, 6:30 am
Gubler (Arizona State University), on Monday, April 8, 2024 Tags: corporate boards, corporate law, directors, Fiduciary duties, Shareholder value, Stakeholders Delaware Supreme Court Holds Entire Fairness Applicable to All Conflicted Controller Transactions Posted by Gregory V. [read post]
15 Feb 2024, 9:05 pm by renholding
On January 24, 2024, the Securities and Exchange Commission (SEC) adopted final rules that impose significant additional procedural and disclosure requirements on initial public offerings (IPOs) by special purpose acquisition companies (SPACs) and in business combination transactions involving SPACs (de-SPACs). [read post]
17 Jan 2024, 9:01 pm by renholding
McCormick of the Court of Chancery addressed an issue of first impression in Crispo v. [read post]
16 Jan 2024, 1:19 pm by Kevin LaCroix
According to a story by Shaud Tavakoli of Skadden Arps Slate Meagher & Flom LLP in Westlaw, short-sellers “take matters into their own hands, preparing and publishing purported ‘research’ reports detailing their rationales for expecting a stock price decline in the hopes of triggering or accelerating a market reaction. [read post]
9 Jan 2024, 6:47 am by Dan Bressler
Zappia asserted that the proxy statement failed to disclose that Skadden, Arps, Slate, Meagher & Flom, the law firm hired to advise Myovant’s special committee for the merger, had a conflict of interest because it also represented other companies in the Sumitomo Group, a network of Japanese businesses that included Sumitovant Biopharma and its corporate parent Sumitomo Pharma Co. [read post]
17 Nov 2023, 6:30 am
Marks, and Allison Sloto, Milbank LLP, on Friday, November 10, 2023 Tags: CARB, Climate Disclosure, SB253, SEC SEC Adopts Short Sale Disclosure Rules Posted by Brian V. [read post]
17 Nov 2023, 6:30 am
Marks, and Allison Sloto, Milbank LLP, on Friday, November 10, 2023 Tags: CARB, Climate Disclosure, SB253, SEC SEC Adopts Short Sale Disclosure Rules Posted by Brian V. [read post]
12 Sep 2023, 5:00 am by James Jolin
Although there has been a great deal of conversation about this decision in relation to the Dobbs v. [read post]
24 Jul 2023, 9:01 pm by renholding
This post comes to us from Skadden, Arps, Slate, Meagher & Flom LLP. [read post]
14 Jul 2023, 6:30 am
Stronski, Skadden, Arps, Slate, Meagher & Flom LLP, on Tuesday, July 11, 2023 Tags: Board composition, directors, Mergers & acquisitions, SEC enforcement, Shareholder activism, universal proxy rule X Corp. v. [read post]
14 Jul 2023, 6:30 am
Stronski, Skadden, Arps, Slate, Meagher & Flom LLP, on Tuesday, July 11, 2023 Tags: Board composition, directors, Mergers & acquisitions, SEC enforcement, Shareholder activism, universal proxy rule X Corp. v. [read post]